We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+3.24%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$33.7B
AUM Growth
+$1.52B
Cap. Flow
+$861M
Cap. Flow %
2.55%
Top 10 Hldgs %
14.52%
Holding
3,141
New
144
Increased
1,491
Reduced
1,301
Closed
155

Sector Composition

Rank Sector Weight
1 Healthcare 14.29%
2 Financials 14.18%
3 Technology 13.8%
4 Industrials 10.4%
5 Consumer Discretionary 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GIG
2951
DELISTED
GigPeak, Inc.
GIG
$66K ﹤0.01%
+33,913
New +$84.4K
OCUL icon
2952
Ocular Therapeutix
OCUL
$1.82B
$65K ﹤0.01%
13,054
-1,900
-13% -$18.8K
VCYT icon
2953
Veracyte
VCYT
$3.54B
$65K ﹤0.01%
13,003
+450
+4% +$2.41K
VRAY
2954
DELISTED
ViewRay, Inc.
VRAY
$63K ﹤0.01%
+15,333
New +$70.1K
MJCO
2955
DELISTED
Majesco
MJCO
$63K ﹤0.01%
+11,917
New +$69.4K
CLD
2956
DELISTED
Cloud Peak Energy Inc
CLD
$57K ﹤0.01%
27,760
-84,217
-75% -$172K
AMPE
2957
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$56K ﹤0.01%
+145
New +$158K
GEN
2958
DELISTED
Genesis Healthcare, Inc.
GEN
$56K ﹤0.01%
31,731
-17,765
-36% -$36.2K
AUY
2959
DELISTED
Yamana Gold, Inc.
AUY
$55K ﹤0.01%
10,580
NWG icon
2960
NatWest
NWG
$75.4B
$54K ﹤0.01%
10,698
SENS icon
2961
Senseonics Holdings Inc
SENS
$257M
$54K ﹤0.01%
+689
New +$48.3K
LPCN icon
2962
Lipocine
LPCN
$17.4M
$53K ﹤0.01%
+1,027
New +$159K
III icon
2963
Information Services Group
III
$197M
$52K ﹤0.01%
+13,744
New +$54.3K
FBIO icon
2964
Fortress Biotech
FBIO
$104M
$44K ﹤0.01%
+1,089
New +$50.7K
CVRS
2965
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
$43K ﹤0.01%
30,022
+11,505
+62% +$13.3K
GLF
2966
DELISTED
GulfMark Offshore, Inc. Common Stock
GLF
$40K ﹤0.01%
12,816
-38,994
-75% -$178K
HHS icon
2967
Harte-Hanks
HHS
$15.9M
$33K ﹤0.01%
2,056
-7,166
-78% -$127K
BAS
2968
DELISTED
Basis Energy Services, Inc.
BAS
$28K ﹤0.01%
29
-112
-79% -$144K
AST
2969
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$28K ﹤0.01%
+11,664
New +$42.2K
ERN
2970
DELISTED
Erin Energy Corp
ERN
$26K ﹤0.01%
10,940
-13,170
-55% -$27.6K
CVEO icon
2971
Civeo
CVEO
$349M
$25K ﹤0.01%
1,148
-13,369
-92% -$274K
VHI icon
2972
Valhi
VHI
$385M
$25K ﹤0.01%
1,301
-850
-40% -$18.7K
GGB icon
2973
Gerdau
GGB
$9.72B
$22K ﹤0.01%
14,994
+1,260
+9% +$1.86K
NM
2974
DELISTED
Navios Maritime Holdings Inc.
NM
$22K ﹤0.01%
2,717
-10,359
-79% -$110K
CBR
2975
DELISTED
CIBER Inc.
CBR
$21K ﹤0.01%
14,321
-119,931
-89% -$204K

Similar funds

RhumbLine Advisers's Q2 2016 Portfolio in Review

As of Q2 2016, RhumbLine Advisers held 3,141 positions worth $33.7B, up 4.7% from $32.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

RhumbLine Advisers's Q2 2016 filing shows 144 new, 1,491 increased, 1,301 reduced and 155 closed positions. Its largest new stake was S&P Global: 401,386 shares worth $43.1M. The largest sale was TIME WARNER CABLE INC NEW COM STK, an estimated $86.8M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Financials and Technology.

  • RhumbLine Advisers's largest Q2 2016 buy was S&P Global: 401,386 shares worth $43.1M.
  • RhumbLine Advisers added most to ExxonMobil in Q2 2016, an estimated $33.4M increase.
  • RhumbLine Advisers's biggest Q2 2016 reduction was Coca-Cola Europacific Partners, cutting an estimated $16.1M.
  • RhumbLine Advisers fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $86.8M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $33.7B portfolio in Q2 2016.
  • RhumbLine Advisers opened 144 new positions and closed 155 in Q2 2016.
  • RhumbLine Advisers's portfolio value rose 4.7% quarter-over-quarter to $33.7B.

Based on RhumbLine Advisers's 13F filing for Q2 2016, filed 11 Aug 2016.